Brazilian newspaper O Globo:
Could you talk a little bit about China's position on intellectual property on public health issues, especially on COVID measures, not only vaccines but the testing for example.
Hu Wenhui:
Thanks for your question. As many are concerned, we have attached importance to intellectual property related to the COVID-19. The CNIPA has launched a special green channel for quick review of patent applications related to the COVID-19. For intellectual property information services related to the COVID-19, we have also specially set up a professional service website for the public and professionals to inquire about relevant information. In this way, we have done our part to support the development of vaccines and the prevention and control of the pandemic. That's all I have to say in regards to that topic. Thank you.
Xing Huina:
Thank you, Mr. Hu, and thanks to the other three speakers. Today's press conference is now concluded. Thank you, journalists from the media. Goodbye, everyone.
Translated and edited by Cui Can, Liu Qiang, Liu Jianing, Zhang Rui, Gong Yingchun, Li Huiru, Wang Mengru, Chen Xia, Xu Xiaoxuan, Huang Shan, Wang Yiming, Yan Xiaoqing, Zhou Jing, Wang Qian, Zhu Bochen, Yuan Fang, Zhang Liying, David Ball, Jay Birbeck, and Drew Pittock. In case of any discrepancy between the English and Chinese texts, the Chinese version is deemed to prevail.
